Shingles is fundamentally a disease of the nervous system, not just the skin. The blistering rash that most people associate with it is only the visible surface of an infection that lives inside nerve cells, travels along nerve fibers, and can damage neural tissue in ways that persist long after the skin heals. Varicella zoster virus, the cause of both chickenpox and shingles, is one of the few human pathogens that takes up permanent residence in neurons, and when it reactivates, the consequences can range from weeks of burning pain to stroke, vision loss, or facial paralysis.
How the Virus Gets Into Your Nerves in the First Place
When you catch chickenpox as a child, the varicella zoster virus does not leave your body after the spots clear up. Instead, it migrates into neurons in the cranial nerve ganglia, dorsal root ganglia, and autonomic ganglia along the entire length of your spine and brainstem.1PubMed Central. Varicella zoster virus latency Once inside a nerve cell, the virus essentially shuts down its own reproduction. It coils its DNA into a circular form, tucks it against the cell’s own chromosomes, and goes quiet. A handful of viral genes remain active at low levels, but no new virus particles are assembled and no infectious virus is released.2PubMed Central. Varicella-zoster virus infection of human dorsal root ganglia in vivo At least five viral genes continue to be transcribed during this dormant period, and unlike some other herpesviruses, varicella zoster produces detectable viral proteins even while latent.3PubMed. Varicella-zoster virus latency in human ganglia
This latent state can last decades. The virus sits inside the nerve cell body, doing almost nothing, kept in check by the immune system’s ongoing surveillance. When something weakens that surveillance, the virus wakes up, begins replicating, and new virus particles travel back down the nerve fiber toward the skin. Laboratory studies have tracked individual viral capsids moving through human axons, reaching the nerve cell body within hours of reactivation.4PubMed Central. Retrograde axonal transport of VZV: kinetic studies in hESC-derived neurons That journey from nerve to skin is what produces the characteristic band-like rash of shingles, confined to the strip of skin served by the affected nerve.
Why Age Is the Biggest Risk Factor
The immune system’s ability to keep varicella zoster in check depends heavily on a specific arm of immunity: the cell-mediated response, which uses specialized immune cells rather than antibodies to hunt down infected cells. Research tracking this immune response across age groups has found that it begins to decline measurably around age 40, and the amount of latent virus in ganglia starts increasing around age 50.5PubMed Central. Varicella‐Zoster Virus‐Specific Cell‐Mediated Immune Response Kinetics and Latent Viral Load Depending on Aging This twin process, a weakening guard and a growing viral load, explains why shingles becomes dramatically more common with age.
Age is not the only factor. People with conditions or treatments that suppress the immune system are also at higher risk, including those on immunosuppressive drugs after organ transplants, people undergoing chemotherapy, and those with HIV or certain inherited immune deficiencies.6PubMed Central. Determinants of neurological syndromes caused by varicella zoster virus (VZV) But most people who get shingles are otherwise healthy older adults whose immune systems have simply aged.
Postherpetic Neuralgia and How It Changes Your Nerves
The most common serious neurological consequence of shingles is postherpetic neuralgia, or PHN, pain that continues for three months or more after the rash has healed. In people over 60 who get shingles, more than 40% go on to develop PHN.7Neurotherapeutics. Issues in the Treatment of Neurological Conditions Caused by Reactivation of Varicella Zoster Virus (VZV) The pain can be burning, stabbing, or aching, and for some people it lasts months or even years.
PHN is now understood to involve changes at both ends of the pain signaling chain. In the peripheral nervous system, the damaged sensory nerve fibers become abnormally excitable, firing pain signals at lower and lower thresholds. In the central nervous system, the spinal cord and brain ramp up their sensitivity to those incoming signals, a process called central sensitization.8PubMed Central. Peripheral and central pathogenesis of postherpetic neuralgia The result is a feedback loop: damaged nerves send too many pain signals, and the brain and spinal cord amplify them further. This combination of peripheral nerve injury, inflammatory signaling, glial cell activation, and oxidative stress is why PHN is increasingly described as a neuroimmune disorder rather than simply a lingering infection.9PubMed Central. Immunoinflammatory mechanisms and emerging therapies for postherpetic neuralgia
The fact that patients with PHN experience different types of pain, including constant burning, shooting pain, and pain triggered by light touch, suggests that multiple distinct nerve damage mechanisms are at work simultaneously in most cases.10PubMed Central. Treatment of postherpetic neuralgia: a review of therapeutic options This helps explain why PHN is notoriously difficult to treat: a single drug rarely addresses all the pathways contributing to the pain.
When Shingles Hits the Eyes and Ears
Shingles does not always appear on the trunk. When the virus reactivates in the trigeminal nerve, which supplies sensation to the face, it can strike the eye, a condition called herpes zoster ophthalmicus. Confocal microscopy studies have documented a measurable drop in corneal nerve density within the first two months after an episode, with the nerve fibers in the cornea thinning out and branching less.11PubMed Central. Corneal nerve changes in herpes zoster ophthalmicus: a prospective longitudinal in vivo confocal microscopy study In many patients, these nerve changes reverse within six months. But in severe cases, the damage can be permanent. One study following patients with herpes zoster ophthalmicus over years found that some showed a complete absence of corneal nerves with no recovery at all, while others demonstrated gradual nerve regrowth and partial restoration of sensation.12PubMed Central. Corneal Re-innervation and Sensation Recovery in Patients with Herpes Zoster Ophthalmicus Whether your corneal nerves recover or not appears to depend on the severity of the initial attack.
Reactivation in the geniculate ganglion, a cluster of nerve cell bodies associated with the facial nerve deep inside the skull, causes Ramsay Hunt syndrome. The defining features are facial paralysis on one side and a vesicular rash on or around the ear. But because the geniculate ganglion sits very close to the hearing and balance nerve, patients frequently also develop tinnitus, hearing loss, vertigo, and nausea.13PubMed Central. Ramsay Hunt syndrome Ramsay Hunt syndrome tends to cause more severe and longer-lasting facial paralysis than the more common Bell’s palsy, and recovery is less predictable.
Stroke and Other Central Nervous System Complications
One of the more alarming discoveries of recent decades is that shingles can cause stroke. The virus can infect the walls of cerebral arteries, triggering inflammation and remodeling of the vessel walls, a process called VZV vasculopathy.14PubMed Central. The relationship between herpes zoster and stroke This arterial damage can narrow or block blood vessels in the brain, leading to ischemic stroke. The risk is highest in the weeks and months following a shingles episode, though it can persist longer. The mechanism appears to involve both the direct viral infection of arterial tissue and the broader inflammatory response triggered by reactivation.15PLOS ONE. Risk of Stroke after Herpes Zoster – Evidence from a German Self-Controlled Case-Series Study
Stroke is not the only central nervous system complication. Reactivation of varicella zoster can also cause encephalitis (inflammation of the brain), myelitis (inflammation of the spinal cord), and meningitis.16PubMed. Severe meningoencephalitis due to late reactivation of Varicella-Zoster virus in an immunocompetent child These are rarer than PHN but far more dangerous. The fact that these complications can occur even in people with otherwise healthy immune systems underscores how aggressively the virus can behave once it escapes immune control.
Autonomic Nerve Damage You Might Not Expect
Because the virus lives in autonomic ganglia as well as sensory ones, reactivation can affect the nerves that control involuntary functions like bladder and bowel control. A systematic review of autonomic dysfunction following varicella zoster infection found that bladder and bowel problems are the most common autonomic complications, resulting from damage to the segmental parasympathetic or sympathetic nerves that emerge from the dorsal root ganglia.17Autonomic Neuroscience: Basic and Clinical. Clinical autonomic dysfunction following varicella-zoster virus infection: A systematic review In some cases, the virus reactivating from autonomic ganglia has been linked to visceral disease, including chronic intestinal pseudo-obstruction, where the gut stops moving food along despite having no physical blockage.18PubMed. Infectious diseases causing autonomic dysfunction
More generalized autonomic problems like orthostatic hypotension, where blood pressure drops when you stand up, are rare with shingles. The pattern is typically segmental: the autonomic damage tends to be limited to the region of the body served by the affected ganglia, rather than causing widespread dysfunction.
The Diagnostic Problem of Shingles Without a Rash
Most doctors diagnose shingles by looking at it. The painful, blistering rash following a single dermatome is distinctive enough that laboratory confirmation is often unnecessary. But a variant called zoster sine herpete throws this approach completely off. In zoster sine herpete, the virus reactivates and causes nerve pain, but the rash never appears.19PubMed Central. Zoster sine herpete: a review Patients have the burning, stabbing dermatomal pain characteristic of shingles, but with no visible lesions for a clinician to spot, they can cycle through misdiagnoses for weeks or longer.
Diagnosing zoster sine herpete requires laboratory testing. PCR analysis, which detects viral DNA, has proven useful even when performed on skin scrapings from intact, non-blistered skin at the site of pain.20PubMed Central. Zoster Sine Herpete: Confirmatory Diagnosis Using Varicella-Zoster Virus DNA Polymerase Chain Reaction Analysis of Intact Skin Scrapings This approach is still not widely used, partly because many clinicians are not thinking about shingles when there is no rash. The condition can affect cranial nerves, spinal nerves, visceral organs, and autonomic nerves, meaning the symptoms of zoster sine herpete can mimic a remarkable range of other conditions.
Before the Rash Appears, Pain Mimics Almost Everything
Even in typical shingles with a rash, the pain precedes the skin eruption in more than 90% of cases.21The American Journal of Medicine. Varicella Zoster with Extended Prodrome: A Case Series This prodromal phase, which can last days to weeks, presents a diagnostic challenge because sharp, localized pain without a visible cause looks like many other emergencies. Depending on where the affected nerve is, the pre-rash pain has been mistaken for a heart attack, pleurisy, gallbladder disease, appendicitis, a herniated disc, and kidney stones. One case report documented a patient whose shingles presented as what appeared to be an acute abdomen, a surgical emergency, before the rash finally appeared days later.22PubMed Central. Shingles (Herpes Zoster) Mimicking Acute Abdomen
The practical lesson is that unexplained, sharply localized pain in a band-like distribution, especially in someone over 50, should raise suspicion for shingles even before any rash develops. Waiting for the rash to appear before starting antiviral treatment means losing precious time during the window when the drugs are most helpful.
Lab Tests and Imaging for Neurological Shingles
When the diagnosis is not obvious from the rash alone, or when neurological complications develop, several tools are available. PCR testing for varicella zoster virus DNA is the most sensitive option. A head-to-head comparison of diagnostic methods found that PCR detected the virus in nearly all positive samples, whereas traditional viral culture caught fewer than half.23PubMed Central. Should varicella-zoster virus culture be eliminated? A comparison of direct immunofluorescence antigen detection, culture, and PCR, with a historical review Multiplex PCR assays can simultaneously test for varicella zoster and herpes simplex virus in both skin swabs and cerebrospinal fluid, which matters when a patient presents with encephalitis or meningitis and the cause could be either virus.24PubMed. Development of a multiplex real-time PCR for the simultaneous detection of herpes simplex and varicella zoster viruses in cerebrospinal fluid and lesion swab specimens
MRI has become the most useful imaging tool for neurological complications of shingles. Among available modalities, it is the best at detecting the subtle signal changes in nerves, spinal cord, and brain tissue caused by VZV reactivation. Newer high-resolution MRI techniques, including three-dimensional fluid-attenuated inversion recovery sequences and MR neurography, have increased the ability to spot inflammation in individual nerves.25PubMed. Neurologic Complications of Varicella-Zoster Virus Reactivation: Clinical and Imaging Features In cases of suspected VZV vasculopathy, specialized vessel wall imaging can show inflammation in the walls of cerebral arteries without requiring invasive angiography. One study of patients with zoster-associated plexopathy, where the virus damages a network of nerves rather than a single nerve, found imaging abnormalities in 70% of patients, most commonly muscle denervation changes and abnormal nerve signals on MRI.26PubMed Central. Imaging Findings in Patients with Zoster-Associated Plexopathy
Antivirals Help the Rash but Are Disappointing for Long-Term Pain
Antiviral drugs like acyclovir and famciclovir are the standard treatment for an active shingles episode. They shorten the duration of the rash and reduce acute pain. But whether they actually prevent postherpetic neuralgia is a different question, and the answer is discouraging. A Cochrane systematic review pooling data from several randomized trials found no meaningful reduction in PHN at four or six months after the rash in patients who received acyclovir compared to placebo. Famciclovir at two different doses also failed to significantly reduce the rate of lingering nerve pain.27PubMed Central. Antiviral treatment for preventing postherpetic neuralgia There was some evidence that antiviral treatment reduced pain at the four-week mark, but the longer-term protection people hope for simply has not materialized in the trials.
This gap between treating the acute infection and preventing chronic nerve damage is one reason vaccination matters so much. The recombinant zoster vaccine was developed specifically to prevent both shingles and postherpetic neuralgia in people aged 50 and older, and clinical trials have shown it to be highly effective at both.28Korean Journal of Pain. Recombinant zoster vaccine (Shingrix®): a new option for the prevention of herpes zoster and postherpetic neuralgia Preventing the reactivation in the first place avoids the nerve damage that antivirals struggle to reverse.
How Shingles Affects Daily Life Beyond the Pain
The impact of shingles, and especially PHN, reaches well beyond the physical sensation of pain. Research into quality of life has found that shingles affects patients across physical, psychological, functional, and social domains, with a clear relationship between the severity of pain and the degree of interference with daily activities.29PubMed Central. The impact of herpes zoster and post-herpetic neuralgia on quality-of-life People with moderate to severe PHN report difficulty sleeping, reduced ability to perform household tasks, withdrawal from social activities, and high rates of anxiety and depression. For older adults who already contend with reduced mobility or other chronic conditions, the addition of relentless nerve pain can be genuinely disabling.
The psychological burden is partly driven by the unpredictability of PHN pain. Many patients describe episodes of sharp pain triggered by things as innocuous as a breeze or the touch of clothing, a phenomenon called allodynia. Living in fear of the next flare makes people guard their bodies, avoid physical contact, and pull back from activities they once enjoyed.
Spinal Cord Stimulation for Stubborn Postherpetic Pain
When standard medications fail to control PHN, some patients turn to neuromodulation, which uses electrical signals to interrupt pain transmission. Spinal cord stimulation, which involves placing a small electrode near the spinal cord, has been studied in patients with PHN who have not responded to conventional treatment. A literature review covering 134 patients found that roughly two-thirds achieved long-term pain relief, with an average pain reduction of about 60%.30PubMed Central. The Effectiveness of Various Types of Electrical Stimulation of the Spinal Cord for Chronic Pain in Patients with Postherpetic Neuralgia
A meta-analysis looking specifically at temporary spinal cord stimulation found that it significantly reduced pain intensity at one, three, and six months, with patients in the stimulation group more than a third more likely to achieve at least a 50% pain reduction at three months compared to controls. The treatment also reduced patients’ need for oral pain medications like pregabalin and improved physical quality-of-life scores from six months onward.31PubMed. From Short-Term Relief to Long-Term Management: A Meta-Analysis of Temporary Spinal Cord Stimulation and Pulsed Radiofrequency in Postherpetic Neuralgia For patients with shingles pain in the face, where standard spinal cord stimulation electrode placement does not reach, high cervical electrode placement at the top of the spine combined with direct stimulation of the affected facial nerve has shown promise in case reports.32PubMed Central. Case Report: Short-Term Spinal Cord Stimulation and Peripheral Nerve Stimulation for the Treatment of Trigeminal Postherpetic Neuralgia in Elderly Patients These interventional approaches remain second-line options, used when medications have failed, but they represent a meaningful advance for people whose pain was previously untreatable.